[HTML][HTML] A new definition and refocus of pharmaceutical care: the Barbate Document
R Morillo-Verdugo, MÁ Calleja-Hernández… - Farmacia …, 2020 - Elsevier
Objective To propose an updated definition of Pharmaceutical Care based on the Capacity-
Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its …
Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its …
Deprescribing of non-antiretroviral therapy in HIV-infected patients
Purpose In recent decades, the life expectancy of HIV-infected patients has increased
considerably, to the extent that the disease can now be considered chronic. In this context of …
considerably, to the extent that the disease can now be considered chronic. In this context of …
A new pharmaceutical care concept: more capable, motivated, and timely
R Morillo-Verdugo, MÁ Calleja-Hernández… - Hospital …, 2019 - journals.sagepub.com
Taking another differential leap, it has been years since the clinical practice model of the
American Society of Health-System Pharmacists advocated the use of pharmacotherapeutic …
American Society of Health-System Pharmacists advocated the use of pharmacotherapeutic …
Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV
R Morillo-Verdugo, A Lazaro-Lopez… - Journal of …, 2022 - Taylor & Francis
Objective To compare patient experience in a real-life population of people living with HIV
(PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation …
(PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation …
Clinical impact of the capacity-motivation-opportunity pharmacist-led intervention in people living with HIV in Spain, 2019–2020
R Morillo-Verdugo, MLA Robustillo-Cortes… - Journal of …, 2022 - Taylor & Francis
Background People living with HIV (PLWH) have significantly enhanced their life
expectancy. Consequently, age-associated comorbidities and related health conditions are …
expectancy. Consequently, age-associated comorbidities and related health conditions are …
Potentially inappropriate prescriptions and therapeutic complexity in older HIV patients with comorbidities
JM Vinuesa-Hernando, M Gimeno-Gracia… - International Journal of …, 2021 - Springer
Background: The prolonged current survival of human immunodeficiency virus (HIV) patients
exposes them to new problems arising from the comorbidities they face. Objectives: To …
exposes them to new problems arising from the comorbidities they face. Objectives: To …
[HTML][HTML] High level of medication regimen complexity index correlate with worse quality of life in people living with HIV
E Contreras-Macías, A Gutiérrez-Pizarraya… - Revista Española de …, 2021 - ncbi.nlm.nih.gov
Objectives People living with HIV (PLWHIV) have now a near-normal life expectancy and
thus, a higher risk of polypharmacy. The main objective was to assess the correlation …
thus, a higher risk of polypharmacy. The main objective was to assess the correlation …
Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 …
A Caso-González, J Núñez-Rodríguez… - Anales del Sistema …, 2022 - europepmc.org
Background We aimed to assess the effectiveness on adherence to treatment with biologic
disease modifying anti-rheumatic drugs (b-DMARD) and experience with providers of …
disease modifying anti-rheumatic drugs (b-DMARD) and experience with providers of …
[HTML][HTML] Una nueva definición y reenfoque de la atención farmacéutica: el Documento de Barbate
R Morillo-Verdugo, MÁ Calleja-Hernández… - Farmacia …, 2020 - SciELO Espana
MORILLO-VERDUGO, Ramón; CALLEJA-HERNANDEZ, Miguel Ángel; ROBUSTILLO-
CORTES, María de las Aguas y POVEDA-ANDRES, José Luis. A new definition and refocus …
CORTES, María de las Aguas y POVEDA-ANDRES, José Luis. A new definition and refocus …
[HTML][HTML] Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients
R Morillo-Verdugo… - Revista Española de …, 2019 - ncbi.nlm.nih.gov
Influence of pharmacist intervention, based on CMO model, to improve activation in HIV
patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
patients - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …